CD90 Is a Diagnostic Marker to Differentiate Between Malignant Pleural Mesothelioma and Lung Carcinoma With Immunohistochemistry.

Saved in:
Bibliographic Details
Title: CD90 Is a Diagnostic Marker to Differentiate Between Malignant Pleural Mesothelioma and Lung Carcinoma With Immunohistochemistry.
Authors: Kiyoko Kawamura1, Kenzo Hiroshima2, Takeo Suzuki3, Kuan Chai3, Naoto Yamaguchi3, Masato Shingyoji4, Toshikazu Yusa5, Yuji Tada6, Yuichi Takiguchi7, Koichiro Tatsumi6, Hideaki Shimada8, Masatoshi Tagawa1,9 mtagawa@chiba-cc.jp
Source: American Journal of Clinical Pathology. Oct2013, Vol. 140 Issue 4, p544-549. 6p. 1 Color Photograph, 3 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:00029173
DOI:10.1309/AJCPM2Z4NGIIPBGE